Oluchi Beatrice Aneke
The reliable delivery of temperature-sensitive pharmaceuticals depends on an unbroken cold chain governed by Good Distribution Practice (GDP). As biologics, vaccines, plasma-derived products, and advanced therapy medicinal products expand their share of the global medicines market, the clinical and economic consequences of thermal excursions have intensified. This paper reviews recent advances in cold chain integrity and GDP across the regulatory and scientific foundations of temperature control, the engineering of thermal protection and monitoring, the digital transformation of distribution networks, and the systemic dimensions of equipment reliability, sustainability, economics, and equitable access. It examines how passive and active thermal protection systems have improved through vacuum insulation and engineered phase change materials, how real-time monitoring built on connected sensing has displaced retrospective data capture, and how predictive analytics, distributed ledgers, and digital twins are reshaping visibility and traceability. Focused attention is given to the ultra-cold and cryogenic chains that support messenger ribonucleic acid vaccines and cell and gene therapies, where chain of identity and chain of custody requirements compound the demands of thermal control. The paper also considers quality risk management and validation, the reliability of refrigeration assets and the role of predictive maintenance, sustainability pressures such as refrigerant phase-down and single-use packaging waste, the economics of failure and of investment in monitoring, the persistent last-mile gaps in low- and middle-income settings, and the lessons drawn from the pandemic deployment of temperature-sensitive vaccines. The central finding is that cold chain assurance is shifting from a document-centric, compliance-driven discipline toward a data-driven, predictive, and risk-based model. Integrating continuous monitoring with analytics and product specific stability budgets offers the clearest path to reducing wastage while preserving patient safety, although interoperability, validation, cybersecurity, and equitable access remain unresolved challenges.